Daunorubicin versus mitoxantrone versus idarubicin as induction and consolidation chemotherapy for adults with acute myeloid leukemia: the EORTC and GIMEMA Groups Study AML-10. (Q37411669)

From Wikidata
Jump to navigation Jump to search
scientific article published on 13 October 2009
edit
Language Label Description Also known as
English
Daunorubicin versus mitoxantrone versus idarubicin as induction and consolidation chemotherapy for adults with acute myeloid leukemia: the EORTC and GIMEMA Groups Study AML-10.
scientific article published on 13 October 2009

    Statements

    Daunorubicin versus mitoxantrone versus idarubicin as induction and consolidation chemotherapy for adults with acute myeloid leukemia: the EORTC and GIMEMA Groups Study AML-10. (English)
    Franco Mandelli
    Maria-Concetta Petti
    Giovanna Meloni
    Filippo Marmont
    Jean-Pierre Marie
    Francesco Di Raimondo
    Felicetto Ferrara
    Robert Zittoun
    Sergio Amadori

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit